Abstract
BackgroundCorrect assessment of response to biologics in rheumatoid arthritis is extremely important regarding future patient management. There is still an open debate about parameters used to better classify the activity...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have